Results 81 to 90 of about 2,816 (159)

Chronic Viral Infections and Al Amyloidosis: An Uncommon Association

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT AL‐amyloidosis is caused by deposition of pathological insoluble proteins in organs and tissues. HIV infection is a multi‐system disorder causing chronic inflammation. We report a case of AL‐amyloidosis associated with HIV suggesting that HIV‐associated immune dysregulation might be critical for pathogenesis of plasma cells dyscrasias and then
Alberto Palladini, Gabriele Cusumano, Ottavio Martellucci, Antonietta Gigante, Gabriella D'Ettorre, Maria Teresa Petrucci, Maurizio Muscaritoli, Mariangela Palladino   +7 more
wiley   +1 more source

The Diagnostic Value of Interleukin‐2 and Interferon‐γ Induced by Fusion Protein (ESAT‐6/CFP‐10/Rv1985c) for Active Mycobacterium tuberculosis Infection

Journal of Clinical Laboratory Analysis, Volume 39, Issue 5, March 2025.
A total of 970 cases, consisting of 215 active tuberculosis (ATB) cases and 755 non‐active tuberculosis (non‐ATB) cases, were enrolled in this study. The results indicated that the release assays of interleukin‐2 (IL‐2) and interferon‐γ (IFN‐γ) induced by the fusion protein (ESAT—6/CFP—10/Rv1985c) were of great value in differentiating ATB from non‐ATB
Zhipeng Zhao, Runqing Li, Xiuying Zhao, Yujie Wang, Minggui Lin, Qian Wei, Xiaochen Li, Pan Xiong   +7 more
wiley   +1 more source

A Case of AIDS Diagnosed in the Intensive Care Unit with Concurrent Influenza Infection and Pneumocystis jirovecii Pneumonia

Case Reports in Medicine, Volume 2025, Issue 1, 2025.
Introduction: People living with HIV (PLWH) are highly susceptible to respiratory infections, particularly pneumonia, which is often polymicrobial. A rapid decline in CD4 T lymphocytes, especially with concurrent influenza, increases the risk of Pneumocystis jirovecii pneumonia (PCP).
Yeliz Özdemir, İlhan Bahar, Gülfem Ece, Savvas Lampridis   +3 more
wiley   +1 more source

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan

Scientific Reports, 2016
AbstractPerformance of interferon-γ (IFN-γ) release assays still needs to be improved. The data on the performance of QuantiFERON-TB Gold Plus (QFT-Plus), a new-generation of QFT assay are limited. This study evaluated the diagnostic performance of QFT-Plus, and compared to that of QuantiFERON-TB Gold In-Tube (QFT-GIT).
Lina Yi, Yuka Sasaki, Hideaki Nagai, Satoru Ishikawa, Mikio Takamori, Kentaro Sakashita, Takefumi Saito, Kiyoyasu Fukushima, Yuriko Igarashi, Akio Aono, Kinuyo Chikamatsu, Hiroyuki Yamada, Akiko Takaki, Toru Mori, Satoshi Mitarai   +14 more
openaire   +2 more sources

QuantiFERON-TB gold plus in liver transplant candidates: single-center experience

, 2022
Background/Objectives: Latent tuberculosis infection (LTBI) screening prior to orthotopic liver transplant (OLT) is essential. The data on QuantiFERON-TB -Gold Plus (QFT-Plus) in OLT candidates is scarce.
Vianna, Rodrigo, Arosemena, Leopoldo R, Chandorkar, Aditya, Motoa, Gabriel, Simkins, Jacques, Natori, Yoichiro, Mendoza, Maria A, Anjan, Shweta   +7 more
core   +1 more source

Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting

, 2017
Although launched in 2015, little is known about the accuracy of QuantiFERON-TB Gold-Plus (QFT-Plus) for diagnosis of latentM. tuberculosisinfection (LTBI). Unlike its predecessor, QFT-Plus utilizes two antigen tubes to elicit an immune response from CD4+
Madhukar Pai, Mary Spangler, Sara Shu-Hwa Tien, Hee-Won Moon, Rajiv L. Gaur, Niaz Banaei   +5 more
core   +1 more source

Interferon Gamma Release Assays in active Tuberculosis: new medical insights

Microbiologia Medica, 2011
Since first presentation, Interferon γ Release Assays (IGRAs) have had basic and wide application to LTBI, in accordance with international consensus and CDC recommendations, leaving their use in active TB to the field of study and research.We reviewed ...
Sandro Pierdomenico, Sergio Gallazzi, Daniela De Francesco, Carla Cisari, Amedea Giani   +4 more
doaj   +1 more source

Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis

Journal of Clinical Microbiology
This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with ...
Potiandi Serge Diagbouga, Arthur Diakourga Djibougou, Camille Pease, Ariana Alcaide, Audrey Berthoux, Natalie Bruiners, Daniela Maria Cirillo, Ardjouma Combary, Nadine Falchero, Deborah Handler, Antoinette Kaboré, Alfred Lardizabal, Amanda Lopes, Marissa Loubet, Philippe Manivet, Clemence Margain, Valerie Meunier, Faiza Mougari, Alberta Onyuka, Sophie Rivoiron, Tani Sagna, Mathilde Sanvert, Léon Sawadogo, Jacques Simporé, Emmanuelle Cambau, Maria Laura Gennaro   +25 more
doaj   +1 more source

Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study

Viruses
Background: The coexistence of HIV infection and latent tuberculosis infection (LTBI) presents a significant public health concern due to the increased risk of tuberculosis (TB) reactivation and progression to active disease.
Luca Pipitò, Elena Delfina Ricci, Paolo Maggi, Giuseppe Vittorio De Socio, Giovanni Francesco Pellicano, Marcello Trizzino, Raffaella Rubino, Alessandra Lanzi, Lorenzo Crupi, Ilaria Capriglione, Nicola Squillace, Giuseppe Nunnari, Antonio Di Biagio, Paolo Bonfanti, Antonio Cascio   +14 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source